Susquehanna International Group’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-185,800
| Closed | -$424K | – | 13317 |
|
|
2024
Q2 | $424K | Buy |
185,800
+48,700
| +36% | +$186K | ﹤0.01% | 8680 |
|
|
2024
Q1 | $592K | Buy |
137,100
+46,200
| +51% | +$161K | ﹤0.01% | 8094 |
|
|
2023
Q4 | $277K | Buy |
90,900
+56,000
| +160% | +$105K | ﹤0.01% | 9985 |
|
|
2023
Q3 | $50.3K | Sell |
34,900
-23,700
| -40% | -$45.9K | ﹤0.01% | 11305 |
|
|
2023
Q2 | $146K | Buy |
58,600
+31,900
| +119% | +$87.1K | ﹤0.01% | 10607 |
|
|
2023
Q1 | $71.6K | Sell |
26,700
-10,900
| -29% | -$52.4K | ﹤0.01% | 11519 |
|
|
2022
Q4 | $204K | Buy |
37,600
+9,000
| +31% | +$75.4K | ﹤0.01% | 10073 |
|
|
2022
Q3 | $357K | Buy |
28,600
+10,900
| +62% | +$125K | ﹤0.01% | 9358 |
|
|
2022
Q2 | $87K | Sell |
17,700
-18,800
| -52% | -$104K | ﹤0.01% | 11597 |
|
|
2022
Q1 | $277K | Sell |
36,500
-2,100
| -5% | -$19.9K | ﹤0.01% | 10470 |
|
|
2021
Q4 | $394K | Sell |
38,600
-5,300
| -12% | -$67.5K | ﹤0.01% | 9826 |
|
|
2021
Q3 | $589K | Sell |
43,900
-70,000
| -61% | -$1.14M | ﹤0.01% | 8951 |
|
|
2021
Q2 | $2.5M | Sell |
113,900
-202,200
| -64% | -$4.49M | ﹤0.01% | 5417 |
|
|
2021
Q1 | $7.61M | Buy |
316,100
+105,800
| +50% | +$2.46M | ﹤0.01% | 3217 |
|
|
2020
Q4 | $3.78M | Buy |
210,300
+182,200
| +648% | +$2.72M | ﹤0.01% | 3915 |
|
|
2020
Q3 | $325K | Buy |
28,100
+17,000
| +153% | +$281K | ﹤0.01% | 8545 |
|
|
2020
Q2 | $269K | Buy |
+11,100
| New | +$184K | ﹤0.01% | 8544 |
|
|
2020
Q1 | – | Sell |
-12,500
| Closed | -$330K | – | 11041 |
|
|
2019
Q4 | $330K | Sell |
12,500
-14,000
| -53% | -$327K | ﹤0.01% | 7844 |
|
|
2019
Q3 | $604K | Buy |
26,500
+18,500
| +231% | +$583K | ﹤0.01% | 6856 |
|
|
2019
Q2 | $245K | Sell |
8,000
-2,700
| -25% | -$56.8K | ﹤0.01% | 8715 |
|
|
2019
Q1 | $178K | Buy |
+10,700
| New | +$203K | ﹤0.01% | 7943 |
|
|
2018
Q4 | – | Sell |
-12,900
| Closed | -$675K | – | 10173 |
|
|
2018
Q3 | $675K | Buy |
+12,900
| New | +$703K | ﹤0.01% | 5994 |
|
Susquehanna International Group's GTHX Position: Q2 2024 in Review
Susquehanna International Group sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q2 2024, closing a stake of 950,839 shares — an estimated $3.63M sold.
Susquehanna International Group first reported a position in GTHX in Q2 2019 and held it in 19 quarters. The position peaked at $4.81M in Q4 2023. 88 funds tracked by Wall St. Rank hold GTHX as of Q2 2024.
- Susquehanna International Group reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- Susquehanna International Group sold 950,839 G1 Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $3.63M.
- Susquehanna International Group first reported a position in G1 Therapeutics, Inc. Common Stock in Q2 2019 and held it in 19 quarters.
- Susquehanna International Group's G1 Therapeutics, Inc. Common Stock position peaked at $4.81M in Q4 2023.
- 88 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q2 2024.
Based on Susquehanna International Group's 13F filing for Q2 2024, filed 15 Aug 2024.